
September 4, 2026 8:41 AM

A new review found that GLP-1 drugs may improve obstructive sleep apnea (OSA) related to obesity. The effects of tirzepatide (Zepound), which is FDA approved for OSA, were especially notable. GLP-1s improve OSA symptoms by promoting fat loss in the neck, throat, and tongue.